Prediction of Cerebrospinal Fluid (CSF) Pressure with Generative Adversarial Network Synthetic Plasma-CSF Biomarker Pairing
- PMID: 40637963
- DOI: 10.1007/s12021-025-09729-2
Prediction of Cerebrospinal Fluid (CSF) Pressure with Generative Adversarial Network Synthetic Plasma-CSF Biomarker Pairing
Abstract
Non-invasive intracranial pressure (ICP) monitoring can help clinicians safely and efficiently monitor spaceflight-associated neuro-ocular syndrome (SANS), idiopathic intracranial hypertension, and traumatic brain injury in astronauts. Current invasive ICP measurement techniques are unsuitable for austere environments like spaceflight. In this study, we explore the potential of plasma-derived cell-free RNA (cfRNA) biomarkers as non-invasive alternatives to cerebrospinal fluid (CSF) markers for ICP assessment. We conducted a secondary analysis of NASA's Open Science Data Repository datasets 363-364, focusing on plasma and CSF biomarkers related to ICP and neurovascular health. An ensemble model combining Support Vector Machine, Gradient Boosting Regressor, and Ridge Regression was developed to capture plasma-CSF biomarker relationships. To address limited sample size, we employed a Generative Adversarial Network (GAN) to generate synthetic plasma-CSF biomarker pairs, expanding the dataset from 29 to 279 samples. The model's performance was evaluated using Mean Squared Error (MSE) and validated against real biomarker data. The GAN-augmented ensemble model achieved high predictive accuracy with an MSE of 0.0044. Synthetic plasma-CSF pairs closely aligned with actual biomarker distributions, demonstrating their effectiveness in reducing overfitting and enhancing model robustness. Strong correlations between plasma-derived RNA biomarkers and corresponding CSF indicators support their potential as non-invasive proxies for ICP assessment. This study establishes a novel framework for non-invasive ICP monitoring using plasma cfRNA profiles enriched with GAN-generated synthetic data. The approach shows promise for both spaceflight and clinical applications, potentially broadening diagnostic capabilities for ICP-related conditions. However, further validation across diverse populations is necessary, along with careful consideration of bioethical and data security issues associated with synthetic data use in clinical diagnostics.
Keywords: Biomarker Prediction; Generative Adversarial Networks; Intracranial Pressure; Machine Learning in Medicine; Non-invasive Diagnostics.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: Not applicable. This study was a secondary analysis of publicly available NASA datasets (Open Science Data Repository 363–364) and did not involve direct experimentation on human or animal subjects. No IRB approval or consent to participate/publish was required. Conflicts of interest: Andrew G. Lee has received compensation as a speaker for Amgen and Alexion and has served as a consultant for Viridian, Erythreal, Catalyst, AstraZeneca, Bristol Myers Squibb, Stoke, and the U.S. Department of Justice. He is also a consultant for NASA; however, the views expressed in this study are his own and do not necessarily reflect those of NASA or the U.S. government. Ram Jagadeesan is an employee of Cisco and holds stock in the company.
Similar articles
-
A holistic framework for intradialytic hypotension prediction using generative adversarial networks-based data balancing.BMC Med Inform Decis Mak. 2025 Jul 10;25(1):257. doi: 10.1186/s12911-025-03094-5. BMC Med Inform Decis Mak. 2025. PMID: 40635002 Free PMC article.
-
Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosis.medRxiv [Preprint]. 2025 May 30:2024.12.07.24318640. doi: 10.1101/2024.12.07.24318640. medRxiv. 2025. Update in: EBioMedicine. 2025 Jul;117:105805. doi: 10.1016/j.ebiom.2025.105805. PMID: 39830279 Free PMC article. Updated. Preprint.
-
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22. Clin Orthop Relat Res. 2024. PMID: 38517402 Free PMC article.
-
Routine intracranial pressure monitoring in acute coma.Cochrane Database Syst Rev. 2015 Nov 2;2015(11):CD002043. doi: 10.1002/14651858.CD002043.pub3. Cochrane Database Syst Rev. 2015. PMID: 26522651 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
References
-
- Abbasi, M., Santos, B. P., Pereira, T. C., Sofia, R., Monteiro, N. R. C., Simões, C. J. V., Brito, R. M. M., Ribeiro, B., Oliveira, J. L., & Arrais, J. P. (2022). Designing optimized drug candidates with Generative Adversarial Network. Journal of Cheminformatics, 14(1), 40. https://doi.org/10.1186/s13321-022-00623-6 . Erratum.In:JCheminform.2022Aug11;14(1):53.10.1186/s13321-022-00631-6. - DOI - PubMed - PMC
-
- Albrecht LJ, Höwner A, Griewank K, et al (2022) Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype. Clinical and Translational Medicine 12. https://doi.org/10.1002/ctm2.1090
-
- Alhoraibi, L., Alghazzawi, D., & Alhebshi, R. (2024). Generative Adversarial Network-Based Data Augmentation for Enhancing Wireless Physical Layer Authentication. Sensors (Basel), 24(2), 641. https://doi.org/10.3390/s24020641 - DOI - PubMed
-
- Amal, S., Safarnejad, L., Omiye, J. A., Ghanzouri, I., Cabot, J. H., & Ross, E. G. (2022). Use of multi-modal data and machine learning to improve cardiovascular disease care. Frontiers in Cardiovascular Medicine, 27(9), 840262. https://doi.org/10.3389/fcvm.2022.840262 - DOI
-
- Arora, A. (2022). Generative adversarial networks and synthetic patient data: Current challenges and future perspectives. Future Healthcare Journal, 9(2), 190–193. https://doi.org/10.7861/fhj.2022-0013 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources